相关实验视频

Updated: Jul 5, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

与LRRK2 G2019S突变相关的帕金森病临床和生物特征的综合分析:来自PPMI研究的数据

Xiaohui Sun¹, Kaixin Dou¹, Li Xue²

¹Department of Neurology, Affiliated Hospital of Qingdao University, Qingdao, China.

Clinical and translational science

|January 24, 2024

概括

患有LRRK2 G2019S突变的帕金森病患者最初的运动和非运动症状较为严重,但进展较慢. 这突出了LRRK2-G2019S帕金森病的独特疾病轨迹.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
临床神经学临床神经学

背景情况:

氨酸丰富的重复激酶2 (LRRK2) 基因中的G2019S突变是家族性和零星性帕金森病 (PD) 的常见原因.
了解患有这种突变和没有这种突变的PD之间的临床和生物差异对于开发向疗法至关重要.

研究的目的:

为了比较患有LRRK2 G2019S突变 (PD+G2019S) 的帕金森病患者的基线临床特征和纵向进展,与没有 (PD-G2019S) 的患者进行比较.
为了确定区分这两个PD群体的特定运动和非运动症状.

主要方法:

来自帕金森病进展标记计划 (PPMI) 数据库的基线和纵向数据的分析.
临床评估的比较,包括运动障碍学会赞助的统一帕金森病评级尺度 (MDS-UPDRS) 修订,日常生活活动 (ADL),帕金森病结果尺度 (SCOPA) -温度调节,以及帕金森病冲动-强迫性障碍问卷.
统计分析包括多重线性回归和纵向建模,控制混因素和使用错误发现率 (FDR) 调整.

主要成果:

与PD-G2019S相比,PD+G2019S患者在基线时表现出更严重的运动功能障碍 (较高的MDS-UPDRS得分) 和增加的非运动症状 (较低的ADL,较高的SCOPA-Thermoregulatory得分).
尽管最初的表现更为严重,但PD+G2019S组的运动和非运动症状的整体进展随着时间的推移而变慢.
纵向分析显示,在两组之间,MDS-UPDRS,冲动强迫障碍,温度调节和ADL得分的进展率存在显著差异.

结论:

与LRRK2 G2019S突变相关的帕金森病呈现出明显的临床特征,以更严重的基线运动和非运动症状为特征.
与非突变载体相比,LRRK2 G2019S突变与较慢的疾病进展轨迹有关.
这些发现强调了基因分析对于理解PD异质性和预测疾病进程的重要性.

更多相关视频

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Assaying the Kinase Activity of LRRK2 in vitro

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...